|
Volumn 33, Issue 1-2, 2001, Pages 635-636
|
Low-dose, short-term treatment with anti-CD4 monoclonal antibody prolongs corneal allograft survival
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MONOCLONAL ANTIBODY;
OKT 4;
OX 35;
OX 38;
UNCLASSIFIED DRUG;
ALLOGRAFT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CORNEA TRANSPLANTATION;
DRUG EFFICACY;
GRAFT REJECTION;
GRAFT SURVIVAL;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD4;
CORNEAL TRANSPLANTATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
RATS;
RATS, INBRED F344;
RATS, INBRED WF;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0035084135
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02178-3 Document Type: Conference Paper |
Times cited : (8)
|
References (8)
|